-
-
Overview
-
Infliximab (Remicade) was associated to the development of anti-Infliximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Remicade®. This might lead to severe complications. The shikari Antibody to Infliximab ELISA Kit can be efficiently used for monitoring anti-Infliximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Infliximab antibodies.
Please contact us at for specific academic pricing.
More Details
-
- Properties
- Applications
-
Overview
SHIKARI® ANTIBODY TO INFLIXIMAB (Remicade®) Quantitative ELISA (Q-ATI)
SHIKARI® ANTIBODY TO INFLIXIMAB (Remicade®) Quantitative ELISA (Q-ATI)
Catalog Number:
EK01315786MAT
Mfr. No.:
INF-QNS-REMI
Price:
Size:
96 tests
Quantity:
Add to Cart:
.